Livzon Pharmaceutical Group

 Livzon Pharmaceutical Group [Photo/livzon.com.cn]

Founded in January 1985, Livzon Pharmaceutical Group is a comprehensive pharmaceutical enterprise integrating research & development (R&D), production, and marketing of medical products. By 2017, the total assets of the company were over 16 billion yuan ($2.36 billion), the annual turnover was 8.53 billion yuan, and the total investment in R&D exceeded 575 million yuan. The company is one of the few pharmaceutical companies in China to be listed on both the A and H share market.

Livzon Pharmaceutical Group has complete modern industrial chains and product groups, focusing on manufacturing chemical drugs, Chinese patent medicines, active pharmaceutical ingredients, and microsphere and diagnostic reagents. Its products in production and on sale cover a wide variety of fields including digestion, cardiovascular and cerebrovascular, anti-infectives anti-tumor, reproductive endocrine, traditional Chinese medicine, and immunotherapy . 

The company has won many national honors in recent years, such as Top 20 Most Competitive Listed Pharmaceutical Companies, Top 10 Best Listed Companies in Corporate Governance, Top 10 Listed Enterprises for Investment Value, Top 500 Enterprises with the Highest Brand Value, Top 20 in R&D Strength in the Pharmaceutical Industry, and Top 10 in Bio-Pharmaceutical R&D Strength. 

The company boasts an acclaimed international biomedical R&D team with top experts and talents. Currently, it employs more than 60 PHD holders and has made progress in the R&D of monoclonal biopharmaceuticals, long-acting microsphere preparations, and precision medical treatment. 

Livzon Pharmaceutical Group is dedicated to the improvement of human life and health. It aims to provide world leading specialty drugs and to develop its business of precision medical treatment.

Address: 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong Province

Website: www.livzon.com.cn